1. Exosomal miRNA Biomarker Panel for Pancreatic Ductal Adenocarcinoma Detection in Patient Plasma: A Pilot Study
   Amy Makler et al, 2023, IJMS CrossRef
2. Electrochemical immunoplatform to help managing pancreatic cancer
   Víctor Pérez-Ginés et al, 2023, Journal of Electroanalytical Chemistry CrossRef
3. Can combined use of tumor markers in pancreatic cancer be a solution to short- and long-term consequences?: A retrospective study
   Ebru Esen et al, 2023 CrossRef
4. Raman Scattering-Based Optical Sensing Of Chronic Liver Diseases
   Khaled Alkhuder, 2023, Photodiagnosis and Photodynamic Therapy CrossRef
5. Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with stage III or IV pancreatic ductal adenocarcinoma
   Benjamin E. Stubbe et al, 2023, Pancreatology CrossRef
6. Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
   Julien Taieb et al, 2023, BMC Cancer CrossRef
7. Feasibility of 125I brachytherapy combined with arterial infusion chemotherapy in patients with advanced pancreatic cancer
   Shujing Huang et al, 2023 CrossRef
8. A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma
   Kosta Stosic et al, 2023, Cells CrossRef
9. Biological risk based on preoperative serum CA19‐9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcinoma
   Shaofei Chang et al, 2023, Cancer Reports CrossRef
10. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning
    Zhongyu Yuan et al, 2023, Abdom Radiol CrossRef
11. Significantly Elevated CA 19-9 after COVID-19 Vaccination and Literature Review of Non-Cancerous Cases with CA 19-9 > 1000 U/mL
    Jakub Ciesielka et al, 2024, JCM CrossRef
12. Unlocking the potential of oncology biomarkers: advancements in clinical theranostics
    Ankit Kumar Dubey et al, 2024 CrossRef
13. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present
    Muhammad Begawan Bestari et al, 2024, Biomolecules CrossRef
14. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer
    Xin Gu et al, 2024, Cancers CrossRef
15. A simplified lateral flow immunosensor for the assay of carcinoembryonic antigen in low-resource settings
    Ioanna Tsogka et al, 2024, Anal. Methods CrossRef
16. Evaluation of the diagnostic and prognostic clinical values of circulating tumor DNA and cell-free DNA in pancreatic malignancies: a comprehensive meta-analysis
    Mehmet Emin Arayici et al, 2024, Front. Oncol. CrossRef
17. The diagnostic value of pleural effusion/serum ratio of carcinoembryonic antigen and pleural effusion/serum ratio of interferon-γ in classification of pleural effusion
    Shu-hui Liang et al, 2024 CrossRef
18. Construction of a combined prognostic model for pancreatic ductal adenocarcinoma based on deep learning and digital pathology images
    Kaixin Hu et al, 2024, BMC Gastroenterol CrossRef
19. Ex-Vivo 3D Cellular Models of Pancreatic Ductal Adenocarcinoma
    Ivana Acimovic et al, 2025, Pancreas CrossRef